BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 36676146)

  • 1. The Concept of Cancer Stem Cells: Elaborating on ALDH1B1 as an Emerging Marker of Cancer Progression.
    Tsochantaridis I; Roupas A; Mohlin S; Pappa A; Voulgaridou GP
    Life (Basel); 2023 Jan; 13(1):. PubMed ID: 36676146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldehyde dehydrogenase 1B1 (ALDH1B1) is a potential biomarker for human colon cancer.
    Chen Y; Orlicky DJ; Matsumoto A; Singh S; Thompson DC; Vasiliou V
    Biochem Biophys Res Commun; 2011 Feb; 405(2):173-9. PubMed ID: 21216231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aldehyde Dehydrogenase 1B1 Is Associated with Altered Cell Morphology, Proliferation, Migration and Chemosensitivity in Human Colorectal Adenocarcinoma Cells.
    Tsochantaridis I; Roupas A; Voulgaridou GP; Giatromanolaki A; Koukourakis MI; Panayiotidis MI; Pappa A
    Biomedicines; 2021 Jan; 9(1):. PubMed ID: 33419031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldehyde Dehydrogenase 1B1 Is Implicated in DNA Damage Response in Human Colorectal Adenocarcinoma.
    Tsochantaridis I; Kontopoulos A; Voulgaridou GP; Tsifintaris M; Triantafyllou C; Pappa A
    Cells; 2022 Jun; 11(13):. PubMed ID: 35805102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aldehyde dehydrogenases in cancer stem cells: potential as therapeutic targets.
    Clark DW; Palle K
    Ann Transl Med; 2016 Dec; 4(24):518. PubMed ID: 28149880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Multifaceted Role of Aldehyde Dehydrogenases in Prostate Cancer Stem Cells.
    Püschel J; Dubrovska A; Gorodetska I
    Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting Aldehyde Dehydrogenases to Eliminate Cancer Stem Cells in Gynecologic Malignancies.
    Muralikrishnan V; Hurley TD; Nephew KP
    Cancers (Basel); 2020 Apr; 12(4):. PubMed ID: 32295073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting colorectal cancer with small-molecule inhibitors of ALDH1B1.
    Feng Z; Hom ME; Bearrood TE; Rosenthal ZC; Fernández D; Ondrus AE; Gu Y; McCormick AK; Tomaske MG; Marshall CR; Kline T; Chen CH; Mochly-Rosen D; Kuo CJ; Chen JK
    Nat Chem Biol; 2022 Oct; 18(10):1065-1075. PubMed ID: 35788181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colon carcinogenesis: influence of Western diet-induced obesity and targeting stem cells using dietary bioactive compounds.
    Kasdagly M; Radhakrishnan S; Reddivari L; Veeramachaneni DN; Vanamala J
    Nutrition; 2014; 30(11-12):1242-56. PubMed ID: 25280404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer stem cells: progress and challenges in lung cancer.
    Templeton AK; Miyamoto S; Babu A; Munshi A; Ramesh R
    Stem Cell Investig; 2014; 1():9. PubMed ID: 27358855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aldehyde dehydrogenases and cancer stem cells.
    Xu X; Chai S; Wang P; Zhang C; Yang Y; Yang Y; Wang K
    Cancer Lett; 2015 Dec; 369(1):50-7. PubMed ID: 26319899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lung cancer stem cells-origin, characteristics and therapy.
    Prabavathy D; Swarnalatha Y; Ramadoss N
    Stem Cell Investig; 2018; 5():6. PubMed ID: 29682513
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aldehyde Dehydrogenase 1 (ALDH1) Is a Potential Marker for Cancer Stem Cells in Embryonal Rhabdomyosarcoma.
    Nakahata K; Uehara S; Nishikawa S; Kawatsu M; Zenitani M; Oue T; Okuyama H
    PLoS One; 2015; 10(4):e0125454. PubMed ID: 25915760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aldehyde dehydrogenase 1B1: a novel immunohistological marker for colorectal cancer.
    Matsumoto A; Arcaroli J; Chen Y; Gasparetto M; Neumeister V; Thompson DC; Singh S; Smith C; Messersmith W; Vasiliou V
    Br J Cancer; 2017 Nov; 117(10):1537-1543. PubMed ID: 28881356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutathione metabolism is essential for self-renewal and chemoresistance of pancreatic cancer stem cells.
    Jagust P; Alcalá S; Sainz Jr B; Heeschen C; Sancho P
    World J Stem Cells; 2020 Nov; 12(11):1410-1428. PubMed ID: 33312407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyaluronic acid hydrogels with defined crosslink density for the efficient enrichment of breast cancer stem cells.
    Tan S; Yamashita A; Gao SJ; Kurisawa M
    Acta Biomater; 2019 Aug; 94():320-329. PubMed ID: 31125725
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular pathology underlying the robustness of cancer stem cells.
    Yoshida GJ; Saya H
    Regen Ther; 2021 Jun; 17():38-50. PubMed ID: 33869685
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling.
    Kim D; Choi BH; Ryoo IG; Kwak MK
    Cell Death Dis; 2018 Aug; 9(9):896. PubMed ID: 30166520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aldehyde Dehydrogenase 1B1 as a Modulator of Pancreatic Adenocarcinoma.
    Singh S; Arcaroli JJ; Orlicky DJ; Chen Y; Messersmith WA; Bagby S; Purkey A; Quackenbush KS; Thompson DC; Vasiliou V
    Pancreas; 2016 Jan; 45(1):117-22. PubMed ID: 26566217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.